Daxin Pharmaceutical

Chongqing Daxin Pharmaceutical Joint-stock Co., Ltd. under Peking University International Hospital Group is a core pharmaceutical enterprise of Founder Group. It has been honored as a National Torch Plan key high-tech enterprise, a national key enterprise in the chemical pharmaceutical industry, and one of China's top 100 pharmaceutical companies. It has also won the title of "Top 50 Industrial Enterprises in Chongqing" nine times, and is a rapidly growing star pharmaceutical company. Founded in 1941, the company is located in the scenic backyard of Chongqing - Beibei District. After more than 60 years of development, it has become a comprehensive pharmaceutical enterprise oriented by biotechnology, with equal emphasis on active pharmaceutical ingredients (APIs) and pharmaceutical preparations. The company adheres to a people-oriented approach, firmly believes that talent is the primary resource, and focuses on cultivating professional and technical personnel. Among its over 1,000 registered employees, there are more than 500 professional and technical personnel and senior technicians. Under a modern human resource management system, the company has established scientific personnel, compensation, and welfare systems, focusing on cultivating internal key talents while recruiting outstanding talents from all over. The company mainly produces APIs, pharmaceutical preparations, and pharmaceutical intermediates in cardiovascular, antibiotic, immunomodulatory, plasma substitute, and other categories, totaling more than 120 varieties and specifications. The company has a sound quality assurance system and fully passed national GMP certification in 2003, with four APIs including tobramycin passing the US FDA certification. The company has a high-quality, efficient, and professional marketing team with distinctive innovation characteristics, and has established smooth sales networks across the country, covering all provinces, municipalities, and autonomous regions. Exported products are sold to more than 20 countries and regions including the US, Europe, and Southeast Asia. Daxin Pharmaceutical will always adhere to the business philosophy of "quality as the foundation, cost as the core, and service as the guarantee," rely on Founder Group's brand resources, and pursue integrity in business, serving society and dedicating to human health as its eternal goal, striving unremittingly to make Daxin Pharmaceutical a leading biomedical enterprise in Western China.